kısım 1 temel kalp yetersizliÄi - Rasim Enar
kısım 1 temel kalp yetersizliÄi - Rasim Enar
kısım 1 temel kalp yetersizliÄi - Rasim Enar
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Kalp Yetersizliğinde Elektriksel Tedavi 239<br />
21. Moss AJ, Hall WJ, Cannom DS et al. Improved survival<br />
with an implanted defibrillator sustained ventricular tachycardia.<br />
N Engl J Med 1996;335:1933-40<br />
22. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky<br />
EN, Hafley G, for Multicenter Unsustained Tachycardia<br />
Trial Investigators. A randomized study of the prevention<br />
of sudden death in patients with coronary artery disease N<br />
Engl J Med 1999;341:1882-90<br />
23. Buxton AE, Lee KL, Hafley G, et al. Relation of ejection<br />
fraction and inducible ventricular tachycardia to mode of<br />
death in patients with coronary artery disease. An analysis<br />
of patients enrolled in the multicenter unsustained tachycardia<br />
trial. Circulation 2003;108(1):67-72.<br />
24. Moss AJ, Zareba W, Hall WJ, et al, for Multicenter Automatic<br />
Defibrillator Implantation Trial ınvestigators(MADIT<br />
II). Prophylactıc implantation of a defibrillator in patients<br />
with myocardial infarction and reduced ejection fraction.<br />
N Engl J Med 2002;346:877-83.<br />
25. Wilber DJ, Zareba W, Hall WJ, et al:Time dependence of<br />
mortality risk and defibrillator benefit after myocardial infarction.<br />
Circulation 2004;109(9):1082-4.<br />
26. Pietrasik G, Goldenberg I, McNitt S, et al. Obesity as a risk<br />
factor for sustained ventricular tachyaarhythmias in MA-<br />
DIT II patients. J Cardiovasc Electrophysiol 2007;18(2):181-<br />
4.<br />
27. Singh JP, Hall WJ, McNitt S, et al. Factors influencing appropriate<br />
firing of the implanted defibrillator for ventricular<br />
tachycardia/fibrillation. J Am Coll Cardiol 2005;46(9):1712-<br />
20.<br />
28. Zwanzinger J, Hall WJ, Dick AW, et al. The cost-effectiveness<br />
of implantable defibrillators:results from the multicenter<br />
automatic defibrillator implantation trial J Am Coll<br />
Cardiol 2006;47:2310-8.<br />
29. Bigger JT, for CABG Patch trial Investigators. Prophylactic<br />
use of implanted cardiac defibrillators in patients at<br />
high risk for ventricular tachyarrhthmias. N Engl J Med<br />
1997;337:1569.<br />
30. Hohnloser SH, Kuck KH, Dorian P et al. Randomized trial<br />
of prophylactic implantable cardioverter defibrillator after<br />
acute myocardial infarction. N Engl J Med 2004;351:2481-<br />
2488.<br />
31. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone<br />
versus implantable cardioverter-defibrillator: randomized<br />
trial in patients with nonischemic dilated cardiomyopathy<br />
and asymptomatic nonsustained ventricular tachycardia<br />
–AMIOVIRT. J Am Coll Cardiol 2003;41(10):1707-<br />
12.<br />
32. Bansch D, Antz M, Boczor S, et al. Primary prevention of<br />
sudden death in idiopathic dilated cardiomyopathy:the Cardiomyopathy<br />
Trial(CAT). Circulation 2002;105(12):1453-8.<br />
33. Kadish A, Schaechter A, Subacius H, et al. Prophylactic<br />
defibrillator implantation in patients with nonischemic dilated<br />
cardiomyopathy N Engl J Med 2004;350(21):2151-8.<br />
34. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or implantable<br />
cardioverter-defibrillator for congestive heart failure<br />
N Engl J Med 2005;352(3):225-37.<br />
35. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable<br />
defibrillators for the prevention of mortality in patients<br />
with nonischemic cardiomyopathy. JAMA 2004;292:2874-<br />
2879.<br />
36. Nanthakumar K, Epstein AE, Kay GN, et al. Prophylactic<br />
implantable cardioverter-defibrillator therapy in patients<br />
with left ventricular systolic dysfunction:a pooled<br />
analysis of 10 primary prevention trials. J Am Coll Cardiol<br />
2004;44(11):2166-72.<br />
37. Goldenberg I, Vyas AK, Hall WJ, et al. For the Multicenter<br />
Automatic Defibrillator Implantation Trial Investigators;<br />
Risk stratification for primary implantation of a cardioverter<br />
defibrillator in patients with ischemic left ventricular<br />
dysfunction. J Am Coll Cardiol 2008;51:288-96.<br />
38. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/<br />
AHA/HRS 2008 Guidelines for Device-Based Therapy<br />
of Cardiac Rhythm Abnormalities J Am Coll Cardiol<br />
2008;51:e1-62.<br />
39. The AVID investigators. A comparison of antiarrhythmic<br />
drug therapy with implantable defibrillators in patients resuscitated<br />
from near fatal ventricular arrhythmias. N Engl<br />
J Med 1997;337:1576-83.<br />
40. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable<br />
Defıbrillator Study(CIDS);a randomized trial of the<br />
implantable cardioverter defibrillator against amiodarone.<br />
Circulation 2000;102:748-54.<br />
41. Kuck KH, Cappato R, Siebels J, Ruppel R, Randomized<br />
comparison of antiarrhythmic drug therapy with implantable<br />
defibrillators in patients resuscitated from cardiac<br />
arrest:the Cardiac Arrest Study Hamburg (CASH). Circulation<br />
2000;102:748-54.<br />
42. Bokhari F, Newman D, Greene M et al. Long–term comparison<br />
of the implantable cardioverter defibrillator versus<br />
amiodarone. Circulation 2005;110:112-116.